NCT01148160View on ClinicalTrials.gov

Voriconazole Trough Plasma Levels : Genetic Polymorphism, Efficacy, Safety in Patients With Hematologic Malignancy

TerminatedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Invasive Fungal Infection
Interventions
DRUG

voriconazole

intravenous, oral administration

Trial Locations (1)

138-736

Asan Medical Center, University of Ulsan College of Medicine, Seoul

Sponsors
All Listed Sponsors
lead

Asan Medical Center

OTHER